Stay updated on Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page
- ChecktodayChange DetectedA NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the study’s record history shows a References update alongside a study-status revision.SummaryDifference0.3%

- Check7 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check14 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as release v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check35 days agoChange DetectedA new revision entry v3.7.0 is added to the study record history, and the prior entry v3.6.6 is removed, reflecting an update to the page’s version history.SummaryDifference0.0%

- Check56 days agoChange DetectedAn entry 'Revision: v3.6.6' was added to the study's history page. The previous 'Revision: v3.6.5' entry and the 'References' section were removed, reflecting an update to the record's version history.SummaryDifference0.1%

- Check77 days agoChange DetectedThe history list shows the page revision updated from v3.6.4 to v3.6.5, indicating a new version of the page. The update is limited to the version label and does not affect content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.